Literature DB >> 24030843

[Management of decompensated liver cirrhosis in the intensive care unit].

O Lerschmacher1, A Koch, K Streetz, C Trautwein, F Tacke.   

Abstract

Liver cirrhosis is the end-stage of long-standing chronic liver diseases. The occurrence of complications from liver cirrhosis increases the mortality risk, but the prognosis can be improved by optimal management in the intensive care unit (ICU). Defined diagnostic algorithms allow the etiology and presence of typical complications upon presentation to the ICU to be identified. Acute variceal bleeding requires endoscopic intervention, vasoactive drugs, antibiotics, supportive intensive care measures and, where necessary, urgent transjugular intrahepatic portosystemic shunt (TIPS) procedure. Spontaneous bacterial peritonitis needs to be diagnosed and immediately treated in patients with ascites. Hepatorenal syndrome should be treated by albumin and terlipressin. In case of respiratory failure, differential diagnosis should not only consider pneumonia, pulmonary embolism and cardiac failure, but also hepatic hydrothorax, portopulmonary hypertension and hepatopulmonary syndrome. The feasibility of liver transplantation should be always discussed in patients with decompensated cirrhosis. Artificial liver support devices may only serve as a bridging procedure until transplant.

Entities:  

Mesh:

Year:  2013        PMID: 24030843     DOI: 10.1007/s00063-013-0259-6

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  50 in total

Review 1.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

Review 2.  Pulmonary-Hepatic vascular Disorders (PHD).

Authors:  R Rodríguez-Roisin; M J Krowka; Ph Hervé; M B Fallon
Journal:  Eur Respir J       Date:  2004-11       Impact factor: 16.671

3.  ESPEN Guidelines on Parenteral Nutrition: hepatology.

Authors:  Mathias Plauth; Eduard Cabré; Bernard Campillo; Jens Kondrup; Giulio Marchesini; Tatjana Schütz; Alan Shenkin; Julia Wendon
Journal:  Clin Nutr       Date:  2009-06-11       Impact factor: 7.324

Review 4.  Infectious complications of acute and chronic liver disease.

Authors:  Bettina Leber; Walter Spindelboeck; Vanessa Stadlbauer
Journal:  Semin Respir Crit Care Med       Date:  2012-03-23       Impact factor: 3.119

5.  Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

Authors:  Rafael Bañares; Frederik Nevens; Fin Stolze Larsen; Rajiv Jalan; Agustín Albillos; Matthias Dollinger; Faouzi Saliba; Tilman Sauerbruch; Sebastian Klammt; Johann Ockenga; Albert Pares; Julia Wendon; Tanja Brünnler; Ludwig Kramer; Philippe Mathurin; Manuel de la Mata; Antonio Gasbarrini; Beat Müllhaupt; Alexander Wilmer; Wim Laleman; Martin Eefsen; Sambit Sen; Alexander Zipprich; Teresa Tenorio; Marco Pavesi; Hartmut H-J Schmidt; Steffen Mitzner; Roger Williams; Vicente Arroyo
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

6.  Early use of TIPS in patients with cirrhosis and variceal bleeding.

Authors:  Juan Carlos García-Pagán; Karel Caca; Christophe Bureau; Wim Laleman; Beate Appenrodt; Angelo Luca; Juan G Abraldes; Frederik Nevens; Jean Pierre Vinel; Joachim Mössner; Jaime Bosch
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

Review 7.  Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes.

Authors:  Dennis M Jensen
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

8.  ESPEN Guidelines on Enteral Nutrition: Liver disease.

Authors:  M Plauth; E Cabré; O Riggio; M Assis-Camilo; M Pirlich; J Kondrup; P Ferenci; E Holm; S Vom Dahl; M J Müller; W Nolte
Journal:  Clin Nutr       Date:  2006-05-16       Impact factor: 7.324

Review 9.  [Nutrition and liver failure].

Authors:  M Plauth
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-05-18       Impact factor: 0.840

10.  Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.

Authors:  Barjesh Chander Sharma; Praveen Sharma; Amit Agrawal; Shiv Kumar Sarin
Journal:  Gastroenterology       Date:  2009-06-06       Impact factor: 22.682

View more
  4 in total

1.  [Invasive Candida infections in liver cirrhosis].

Authors:  A Koch; F Tacke
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-07-26       Impact factor: 0.840

2.  Resource utilization and survival among Medicare patients with advanced liver disease.

Authors:  Munkhzul Otgonsuren; Linda Henry; Sharon Hunt; Chapy Venkatesan; Alita Mishra; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2014-08-10       Impact factor: 3.199

3.  Measurement of serum procalcitonin levels for the early diagnosis of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis.

Authors:  Zhao-Hua Cai; Chun-Lei Fan; Jun-Fu Zheng; Xin Zhang; Wen-Min Zhao; Bing Li; Lei Li; Pei-Ling Dong; Hui-Guo Ding
Journal:  BMC Infect Dis       Date:  2015-02-13       Impact factor: 3.090

4.  Efficacy and safety of autologous stem cell transplantation for decompensated liver cirrhosis: A retrospective cohort study.

Authors:  Ming-Fang Wang; You-Bing Li; Xiao-Juan Gao; Hao-Yang Zhang; Su Lin; Yue-Yong Zhu
Journal:  World J Stem Cells       Date:  2018-10-26       Impact factor: 5.326

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.